|
| Exchange Disseminated Time | GKB Ophthalmics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has decided the following:
1. To pass over the dividend for the year 2013-14.
2. Rename the Remuneration Committee as "Nomination & Remuneration Committee", in terms of Section 178 (1) of the Companies Act, 2013.
3. Rename the Shareholder's/Investors Grievance Committee as "Stakeholders Relationship Committee ", in terms of Section 178 (5) of the Companies Act, 2013.
4. Constitute a Risk Management Committee
5. Set up Vigil Mechanism by way of Whistle Blower Policy in terms of Sections 177 of the Companies Act, 2013 and the same will be put up in the Company's website shortly.
6. Wind up GKB Ophthalmics GmbH, Germany, a Wholly Owned Subsidiary (WOS), which has not been doing any business for last several years. |
|
|